Medisca recalls swapped drugs

Share this article:

FDA testing revealed that lots of Medisca's L-citrulline did not contain the drug, but did test positive for medication used to treat vertigo.

The regulator announced the testing results Monday, three days after notifying healthcare professionals of adverse events associated with some of Medisca's medication. L-citrulline is used to treat rare genetic disorders usually found in children.

Medisca has recalled eight lots of the drug.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.